BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23647409)

  • 1. Ciprofloxacin and rifampin have opposite effects on levothyroxine absorption.
    Goldberg AS; Tirona RG; Asher LJ; Kim RB; Van Uum SH
    Thyroid; 2013 Nov; 23(11):1374-8. PubMed ID: 23647409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered intestinal absorption of L-thyroxine caused by coffee.
    Benvenga S; Bartolone L; Pappalardo MA; Russo A; Lapa D; Giorgianni G; Saraceno G; Trimarchi F
    Thyroid; 2008 Mar; 18(3):293-301. PubMed ID: 18341376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a concomitant single oral dose of rifampicin on the pharmacokinetics of pravastatin in a two-phase, randomized, single-blind, placebo-controlled, crossover study in healthy Chinese male subjects.
    Deng S; Chen XP; Cao D; Yin T; Dai ZY; Luo J; Tang L; Li YJ
    Clin Ther; 2009 Jun; 31(6):1256-63. PubMed ID: 19695392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of total thyroxine in dogs after administration of an oral solution of levothyroxine sodium.
    Le Traon G; Burgaud S; Horspool LJ
    J Vet Pharmacol Ther; 2008 Apr; 31(2):95-101. PubMed ID: 18307500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
    Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
    Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acute effect of calcium carbonate on the intestinal absorption of levothyroxine.
    Singh N; Weisler SL; Hershman JM
    Thyroid; 2001 Oct; 11(10):967-71. PubMed ID: 11716045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of famotidine, esomeprazole, and ezetimibe on levothyroxine absorption.
    Ananthakrishnan S; Braverman LE; Levin RM; Magnani B; Pearce EN
    Thyroid; 2008 May; 18(5):493-8. PubMed ID: 18466075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vitamin C on the absorption of levothyroxine in patients with hypothyroidism and gastritis.
    Jubiz W; Ramirez M
    J Clin Endocrinol Metab; 2014 Jun; 99(6):E1031-4. PubMed ID: 24601693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidating rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite.
    Zheng HX; Huang Y; Frassetto LA; Benet LZ
    Clin Pharmacol Ther; 2009 Jan; 85(1):78-85. PubMed ID: 18843263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human thyroxine absorption: age effects and methodological analyses.
    Hays MT; Nielsen KR
    Thyroid; 1994; 4(1):55-64. PubMed ID: 8054862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine.
    Slawik M; Klawitter B; Meiser E; Schories M; Zwermann O; Borm K; Peper M; Lubrich B; Hug MJ; Nauck M; Olschewski M; Beuschlein F; Reincke M
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4115-22. PubMed ID: 17711927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
    Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
    Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites.
    Backman JT; Luurila H; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2005 Aug; 78(2):154-67. PubMed ID: 16084850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of levothyroxine sodium bioavailability: recommendations for an improved methodology based on the pooled analysis of eight identically designed trials with 396 drug exposures.
    Walter-Sack I; Clanget C; Ding R; Goeggelmann C; Hinke V; Lang M; Pfeilschifter J; Tayrouz Y; Wegscheider K
    Clin Pharmacokinet; 2004; 43(14):1037-53. PubMed ID: 15530132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New medications which decrease levothyroxine absorption.
    John-Kalarickal J; Pearlman G; Carlson HE
    Thyroid; 2007 Aug; 17(8):763-5. PubMed ID: 17725434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral and intravenous thyroxine (T4) achieve comparable serum levels for hormonal resuscitation protocol in organ donors: a randomized double-blinded study.
    Sharpe MD; van Rassel B; Haddara W
    Can J Anaesth; 2013 Oct; 60(10):998-1002. PubMed ID: 23884915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.
    Kharasch ED; Hoffer C; Whittington D; Sheffels P
    Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women.
    Krauwinkel W; van Dijk J; Schaddelee M; Eltink C; Meijer J; Strabach G; van Marle S; Kerbusch V; van Gelderen M
    Clin Ther; 2012 Oct; 34(10):2144-60. PubMed ID: 23063375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.